Show simple item record

dc.creatorRamos Esquivel, Allan Eduardo
dc.creatorLandaverde Recinos, Denis
dc.description.abstractBackground: Data regarding the prognostic value of androgen receptor (AR) expression in locally advanced breast cancer (LABC) is limited. We aimed to determine the pathological complete response, defined as ypT0/is and ypN0, in a group of patients with AR-positive breast cancer after preoperative treatment. Methods: We evaluated immunohistochemical AR expression in 40 patients treated in our referral center. Univariate and multivariate models were used to assess the association between AR expression and pathological complete response (pCR). Results: AR expression varied from 75% in estrogen receptor-positive tumors to 11.7% in triple-negative tumors (P < 0.001). Three patients with AR-positive tumors achieved pCR. In the univariate model, AR expression was significantly associated with the absence of pCR (OR = 0.18; 95% CI, 0.04–0.75; P = 0.023). After adjusting for intrinsic breast cancer subtypes, AR-positive tumors had less probability of achieving a pCR compared with AR-negative ones (OR = 12.33; P = 0.046). Conclusions: AR expression was negatively correlated with pCR in our subset of patients with LABC who underwent neoadjuvant chemotherapy.es_ES
dc.rightsCC0 1.0 Universal*
dc.sourceArchives of Breast Cancer, vol. 4(4), p. 124-128es_ES
dc.subjectAndrogen receptores_ES
dc.subjectBreast canceres_ES
dc.subjectNeoadjuvant treatmentes_ES
dc.subject616.994 49 Cáncer de mamaes_ES
dc.titleAndrogen Receptor Expression in Locally Advanced Breast Cancer Predicts Lack of Pathological Complete Response After Neoadjuvant Treatmentes_ES
dc.typeArtículo científicoes_ES
dc.description.procedenceUCR::Vicerrectoría de Docencia::Salud::Facultad de Medicina::Escuela de Medicinaes_ES

Files in this item


This item appears in the following Collection(s)

Show simple item record

CC0 1.0 Universal
Except where otherwise noted, this item's license is described as CC0 1.0 Universal